Bassoy E, Raja R, Rubino Jr T, Coscia F, Goergen K, Magtibay P
Oncoimmunology. 2025; 14(1):2460276.
PMID: 39891409
PMC: 11792853.
DOI: 10.1080/2162402X.2025.2460276.
McKenzie M, Lian G, Pennel K, Quinn J, Jamieson N, Edwards J
Heliyon. 2024; 10(12):e32904.
PMID: 38975078
PMC: 11226910.
DOI: 10.1016/j.heliyon.2024.e32904.
Guo P, Jiang J, Chu R, He F, Ge M, Fang R
Acta Pharm Sin B. 2024; 14(3):1222-1240.
PMID: 38486990
PMC: 10935169.
DOI: 10.1016/j.apsb.2023.12.007.
Yang Q, Lin Z, Xue M, Jiang Y, Chen L, Chen J
J Transl Med. 2024; 22(1):219.
PMID: 38424541
PMC: 10905948.
DOI: 10.1186/s12967-024-05022-z.
Martinez-Lopez A, Garcia-Casas A, Infante G, Gonzalez-Fernandez M, Salvador N, Lorente M
Mol Oncol. 2023; 18(3):620-640.
PMID: 38098337
PMC: 10920093.
DOI: 10.1002/1878-0261.13568.
Is a Highly Expressed Therapy Target in Myxoid Liposarcoma.
Toivanen K, Kilpinen S, Ojala K, Merikoski N, Salmikangas S, Sampo M
Cancers (Basel). 2023; 15(22).
PMID: 38001568
PMC: 10669966.
DOI: 10.3390/cancers15225308.
POTEE mutation as a potential predictive biomarker for immune checkpoint inhibitors in lung adenocarcinoma.
Li Y, Yang Q, Liu Y, Yi H, Ju Y, Qi G
Invest New Drugs. 2023; 41(4):556-563.
PMID: 37318657
DOI: 10.1007/s10637-023-01375-2.
Histaminergic System and Inflammation-Related Genes in Normal Large Intestine and Tissues: Transcriptional Profiles and Relations.
Janikowska G, Janikowski T, Plato M, Mazurek U, Orchel J, Opilka M
Int J Mol Sci. 2023; 24(5).
PMID: 36902343
PMC: 10002554.
DOI: 10.3390/ijms24054913.
Whole genome sequencing of Malaysian colorectal cancer patients reveals specific druggable somatic mutations.
Mohd Yunos R, Mutalib N, Khoo J, Saidin S, Ishak M, Syafruddin S
Front Mol Biosci. 2023; 9:997747.
PMID: 36866106
PMC: 9972984.
DOI: 10.3389/fmolb.2022.997747.
Metabolomic Analysis Reveals that SPHK1 Promotes Oral Squamous Cell Carcinoma Progression through NF-κB Activation.
Hou C, Mao G, Sun Q, Meng Y, Zhu Q, Tang Y
Ann Surg Oncol. 2022; 29(12):7386-7399.
PMID: 35829796
DOI: 10.1245/s10434-022-12098-8.
Gastric Cancer Pre-Stage Detection and Early Diagnosis of Gastritis Using Serum Protein Signatures.
Aziz S, Rasheed F, Zahra R, Konig S
Molecules. 2022; 27(9).
PMID: 35566209
PMC: 9099457.
DOI: 10.3390/molecules27092857.
approach to understand epigenetics of POTEE in ovarian cancer.
Qazi S, Raza K
J Integr Bioinform. 2021; 18(4).
PMID: 34788504
PMC: 8709732.
DOI: 10.1515/jib-2021-0028.
SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis.
Qin Z, Tong H, Li T, Cao H, Zhu J, Yin S
Int J Mol Med. 2021; 48(5).
PMID: 34549307
PMC: 8480383.
DOI: 10.3892/ijmm.2021.5037.
S100P contributes to promoter demethylation and transcriptional activation of SLC2A5 to promote metastasis in colorectal cancer.
Lin M, Fang Y, Li Z, Li Y, Feng X, Zhan Y
Br J Cancer. 2021; 125(5):734-747.
PMID: 34188196
PMC: 8405647.
DOI: 10.1038/s41416-021-01306-z.
N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis Differentially Regulating Ubiquitination of Targets.
Zhu G, Wang F, Li H, Zhang X, Wu Q, Liu Y
Front Oncol. 2021; 11:681366.
PMID: 34136404
PMC: 8201403.
DOI: 10.3389/fonc.2021.681366.
Helicase-like transcription factor-deletion from the tumor microenvironment in a cell line-derived xenograft model of colorectal cancer reprogrammed the human transcriptome-S-nitroso-proteome to promote inflammation and redirect metastasis.
Helmer R, Martinez-Zaguilan R, Kaur G, Smith L, Dufour J, Chilton B
PLoS One. 2021; 16(5):e0251132.
PMID: 34010296
PMC: 8133447.
DOI: 10.1371/journal.pone.0251132.
Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer.
Ottaiano A, Caraglia M, Di Mauro A, Botti G, Lombardi A, Galon J
Cancers (Basel). 2020; 12(10).
PMID: 33096795
PMC: 7589866.
DOI: 10.3390/cancers12103073.
Prognostic implications of metabolism-associated gene signatures in colorectal cancer.
Miao Y, Li Q, Wang J, Quan W, Li C, Yang Y
PeerJ. 2020; 8:e9847.
PMID: 32953273
PMC: 7474523.
DOI: 10.7717/peerj.9847.
SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development.
Shen Z, Li Y, Fang Y, Lin M, Feng X, Li Z
Mol Oncol. 2019; 14(2):387-406.
PMID: 31876369
PMC: 6998659.
DOI: 10.1002/1878-0261.12626.